Company Quick10K Filing
GTY Technology
10-K 2020-12-31 Filed 2021-02-19
10-Q 2020-09-30 Filed 2020-11-05
10-Q 2020-06-30 Filed 2020-08-07
10-Q 2020-03-31 Filed 2020-05-08
10-K 2019-12-31 Filed 2020-03-13
10-Q 2019-09-30 Filed 2019-11-07
10-Q 2019-06-30 Filed 2019-08-09
10-Q 2019-03-31 Filed 2019-05-13
10-K 2018-12-31 Filed 2019-03-18
10-Q 2018-09-30 Filed 2018-11-09
10-Q 2018-06-30 Filed 2018-08-09
10-Q 2018-03-31 Filed 2018-05-10
10-K 2017-12-31 Filed 2018-03-16
10-Q 2017-09-30 Filed 2017-11-13
10-Q 2017-06-30 Filed 2017-08-11
10-Q 2017-03-31 Filed 2017-05-12
10-K 2016-12-31 Filed 2017-03-24
10-Q 2016-09-30 Filed 2016-12-12
8-K 2021-02-16 Earnings, Exhibits
8-K 2020-12-16 Other Events, Exhibits
8-K 2020-12-14 Other Events, Exhibits
8-K 2020-11-25 Enter Agreement, Exhibits
8-K 2020-11-17 Other Events, Exhibits
8-K 2020-11-13 Enter Agreement, Off-BS Arrangement, Regulation FD, Exhibits
8-K 2020-11-05 Earnings, Exhibits
8-K 2020-08-07
8-K 2020-06-23
8-K 2020-05-08
8-K 2020-04-02
8-K 2020-03-24
8-K 2020-03-12
8-K 2020-02-19
8-K 2020-02-14
8-K 2020-02-14
8-K 2020-01-14
8-K 2019-12-12
8-K 2019-11-07
8-K 2019-10-14
8-K 2019-09-16
8-K 2019-08-09
8-K 2019-08-08
8-K 2019-07-02
8-K 2019-06-24
8-K 2019-06-04
8-K 2019-05-20
8-K 2019-05-13
8-K 2019-05-07
8-K 2019-02-19
8-K 2019-02-19
8-K 2019-02-14
8-K 2019-02-08
8-K 2019-02-07
8-K 2019-02-07
8-K 2019-02-04
8-K 2019-02-01
8-K 2019-01-22
8-K 2019-01-14
8-K 2019-01-14
8-K 2018-12-28
8-K 2018-11-23
8-K 2018-11-13
8-K 2018-10-30
8-K 2018-10-22
8-K 2018-10-10
8-K 2018-09-12
8-K 2018-08-28
8-K 2018-06-27
8-K 2018-01-03

GTY Technology Financials

GTYH Metrics, Comps, Filings

Quarterly | Annual

Valuation ($MM)

Market Cap, Enterprise Value

Balance Sheet ($MM)

Assets, Equity

Income Statement ($MM Quarterly)

Revenue, G Profit, Net Income

Cash Flow ($MM Quarterly)

Ops, Inv, Fin

Comps ($'000 TTM) Market Cap Gross Margin EV/EBITDA Ret on Assets Assets Liabilities Revenue G Profit Net Income EBITDA EV
ENETI INC. (NETI)
024 Pharma (EEIG)
Vivus (VVUS) 40,869 77% -17.5 -11% 226,103 289,374 72,620 55,706 -24,956 -13,928 243,484
Clovis Oncology (CLVS) 219,222 0% -0.0 -56% 716,892 804,387 134,050 0 -400,184 -394,255 17,741
Cementos Pacasmayo Saa (CPAC) 4,145,433 0% 2,863,245 1,411,882 0 0 0 0 4,145,433
11 Good Energy (ELVN)
Exantas Capital (XAN)
1347 Capital Corp (TFSC)
Bancorp of New Jersey (BKJ) 122,881 1.0 0% 961,684 868,577 0 0 3,422 14,772 14,360
1PM Industries (OPMZ)
1st Century Bancshares (FCTY)
1st Financial Services Corp (FFIS)
1st United Bancorp (FUBC)
2-Track Global (TTG)
ENTERGY ARKANSAS, LLC (EAI)
21st Century Oncology Holdings (RTSX)
24Holdings (TWFH)
30DC (TDCH)
3D Pioneer Systems (DPSM)
ALABAMA POWER CO (APRCP)

Balance Sheet ($'000)2016-09-302016-12-312017-03-312017-06-302017-09-302017-12-312018-03-312018-06-302018-09-302018-12-312019-03-312019-06-302019-09-30
Cash01,2201,0277826675614032753745222,94725,44416,884
Accounts Receivable5,0958,3318,732
Inventory
PP&E8412,6792,896
Assets180553,505553,979554,798556,122557,446559,046561,439564,155217,733500,664504,298495,323
Accounts Payable691283,1185,124
Long-Term Debt000
Liabilities17219,40919,51319,41519,45619,49019,57519,75322,8789,839149,646135,101135,854
Stockholders' Equity85,0005,0005,0005,0005,0005,0005,0005,0005,000346,018369,197359,469
Income Statement ($'000)2016-09-302016-12-312017-03-312017-06-302017-09-302017-12-312018-03-312018-06-302018-09-302018-12-312019-03-312019-06-302019-09-30
Revenue3,0348,2468,754
Cost of Revenue1,5762,9312,583
Gross Profit1,4585,3156,171
R&D1,4723,1353,003
SG&A101902814161441251973773,0783,73211,8359,323
Tax00-1,149
Net Income-17813699181,2831,2901,5142,216-409-40,052-10,402-8,700
Cash Flow ($'000)2016-09-302016-12-312017-03-312017-06-302017-09-302017-12-312018-03-312018-06-302018-09-302018-12-312019-03-312019-06-302019-09-30
Cash Operating0-86-193-438-106-158-128-302-25,271-43,972-5,871
Cash Investing38,62838,013-783
Cash Financing9,61631,450-1,921